Perceptive Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Perceptive Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,637	Closed	-$1.02M	–	153
2020 Q2	$1.02M	Hold	30,637	–	–	0.02%	112
2020 Q1	$881K	Sell	30,637 -2,805,000	-99%	-$78.1M	0.02%	97
2019 Q4	$55.9M	Sell	2,835,637 -69,363	-2%	-$1.11M	1.11%	20
2019 Q3	$37.6M	Hold	2,905,000	–	–	1.01%	28
2019 Q2	$36.2M	Buy	2,905,000 +30,000	+1%	+$398K	0.83%	30
2019 Q1	$41.8M	Buy	2,875,000 +50,000	+2%	+$639K	1.18%	25
2018 Q4	$31.1M	Buy	2,825,000 +2,800,511	+11,436%	+$39M	1.18%	25
2018 Q3	$644K	Hold	24,489	–	–	0.02%	100
2018 Q2	$501K	Buy	+24,489	New	+$526K	0.01%	109

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Perceptive Advisors's MNTA Position: Q3 2020 in Review

Perceptive Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 30,637 shares — an estimated $1.02M sold.

Perceptive Advisors first reported a position in MNTA in Q2 2018 and held it in 9 quarters. The position peaked at $55.9M in Q4 2019. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Perceptive Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Perceptive Advisors sold 30,637 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.02M.
Perceptive Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2018 and held it in 9 quarters.
Perceptive Advisors's Momenta Pharmaceuticals, Inc. position peaked at $55.9M in Q4 2019.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.